Works matching AU Kramer, Kim

Results: 95

Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G D2 immunotherapy and isotretinoin: a prospective Phase II study.

Published in:

OncoImmunology, 2015, v. 4, n. 7, p. N.PAG, doi. 10.1080/2162402X.2015.1016704

By:

Kushner, Brian H;
Ostrovnaya, Irina;
Cheung, Irene Y;
Kuk, Deborah;
Kramer, Kim;
Modak, Shakeel;
Yataghene, Karima;
Cheung, Nai-Kong V

Publication type:

Article

Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23402-1, doi. 10.4161/onci.23402

By:

Modak, Shakeel;
Kushner, Brian H.;
Kramer, Kim;
Vickers, Andrew;
Irene Y. Cheung;
Nai-Kong V. Cheung

Publication type:

Article

Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients.

Published in:

OncoTargets & Therapy, 2015, v. 8, p. 3323, doi. 10.2147/OTT.S92443

By:

Jiaxin Niu;
Andres, Grant;
Kramer, Kim;
Kundranda, Madappa N.;
Alvarez, Ricardo H.;
Klimant, Eiko;
Parikh, Ankur R.;
Tan, Bradford;
Staren, Edgar D.;
Markman, Maurie

Publication type:

Article

Correction to: Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti‑B7H3 immunotherapy.

Published in:

2021

By:

Kramer, Kim;
Donzelli, Maria A.;
Pessin, Melissa S.

Publication type:

Correction Notice

Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti-B7H3 immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2411, doi. 10.1007/s00262-020-02824-0

By:

Kramer, Kim;
Donzelli, Maria A.;
Pessin, Melissa S.

Publication type:

Article

Osteochondroma in long-term survivors of high-risk neuroblastoma.

Published in:

Cancer (0008543X), 2015, v. 121, n. 12, p. 2090, doi. 10.1002/cncr.29316

By:

Kushner, Brian H.;
Roberts, Stephen S.;
Friedman, Danielle N.;
Kuk, Deborah;
Ostrovnaya, Irina;
Modak, Shakeel;
Kramer, Kim;
Basu, Ellen M.;
Cheung, Nai‐Kong V.

Publication type:

Article

Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era.

Published in:

Cancer (0008543X), 2014, v. 120, n. 13, p. 2050, doi. 10.1002/cncr.28687

By:

Kushner, Brian H.;
Modak, Shakeel;
Kramer, Kim;
LaQuaglia, Michael P.;
Yataghene, Karima;
Basu, Ellen M.;
Roberts, Stephen S.;
Cheung, Nai‐Kong V.

Publication type:

Article

Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody.

Published in:

2013

By:

Kushner, Brian H;
Modak, Shakeel;
Basu, Ellen M;
Roberts, Stephen S;
Kramer, Kim;
Cheung, Nai-Kong V

Publication type:

journal article

Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody.

Published in:

Cancer (0008543X), 2013, v. 119, n. 15, p. 2789, doi. 10.1002/cncr.28137

By:

Kushner, Brian H.;
Modak, Shakeel;
Basu, Ellen M.;
Roberts, Stephen S.;
Kramer, Kim;
Cheung, Nai‐Kong V.

Publication type:

Article

Ifosfamide, carboplatin, and etoposide for neuroblastoma.

Published in:

Cancer (0008543X), 2013, v. 119, n. 3, p. 665, doi. 10.1002/cncr.27783

By:

Kushner, Brian H.;
Modak, Shakeel;
Kramer, Kim;
Basu, Ellen M.;
Roberts, Stephen S.;
Cheung, Nai‐Kong V.

Publication type:

Article

Differential Impact of High-Dose Cyclophosphamide, Topotecan, and Vincristine in Clinical Subsets of Patients With Chemoresistant Neuroblastoma.

Published in:

Cancer (0008543X), 2010, v. 116, n. 12, p. 3054, doi. 10.1002/cncr.25232

By:

Kushner, Brian H.;
Kramer, Kim;
Modak, Shakeel;
Li-Xuan Qin;
Cheung, Nai-Kong V.

Publication type:

Article

Reduced‐dose craniospinal irradiation for central nervous system relapsed neuroblastoma.

Published in:

Pediatric Blood & Cancer, 2020, v. 67, n. 9, p. 1, doi. 10.1002/pbc.28364

By:

Luo, Leo Y.;
Kramer, Kim;
Cheung, Nai‐Kong V.;
Kushner, Brian H.;
Modak, Shakeel;
Basu, Ellen M.;
Roberts, Stephen S.;
Wolden, Suzanne L.

Publication type:

Article

Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.

Published in:

2020

By:

Luo, Leo Y;
Kramer, Kim;
Cheung, Nai-Kong V;
Kushner, Brian H;
Modak, Shakeel;
Basu, Ellen M;
Roberts, Stephen S;
Wolden, Suzanne L

Publication type:

journal article

Central nervous system relapse of rhabdomyosarcoma.

Published in:

2018

By:

De, Brian;
Kinnaman, Michael D.;
Wexler, Leonard H.;
Kramer, Kim;
Wolden, Suzanne L.

Publication type:

journal article

A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma.

Published in:

2018

By:

Kramer, Kim;
Pandit‐Taskar, Neeta;
Humm, John L.;
Zanzonico, Pat B.;
Haque, Sofia;
Dunkel, Ira J.;
Wolden, Suzanne L.;
Donzelli, Maria;
Goldman, Debra A.;
Lewis, Jason S.;
Lyashchenko, Serge K.;
Khakoo, Yasmin;
Carrasquillo, Jorge A.;
Souweidane, Mark M.;
Greenfield, Jeffrey P.;
Lyden, David;
De Braganca, Kevin D.;
Gilheeney, Stephen W.;
Larson, Steven M.;
Cheung, Nai‐Kong V.

Publication type:

journal article

A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.

Published in:

2017

By:

Becher, Oren J.;
Gilheeney, Stephen W.;
Khakoo, Yasmin;
Lyden, David C.;
Haque, Sofia;
Braganca, Kevin C.;
Kolesar, Jill M.;
Huse, Jason T.;
Modak, Shakeel;
Wexler, Leonard H.;
Kramer, Kim;
Spasojevic, Ivan;
Dunkel, Ira J.;
De Braganca, Kevin C

Publication type:

journal article

Safety profile of long-term intraventricular access devices in pediatric patients receiving radioimmunotherapy for central nervous system malignancies.

Published in:

Pediatric Blood & Cancer, 2014, v. 61, n. 9, p. 1590, doi. 10.1002/pbc.25080

By:

Kramer, Kim;
Smith, Mariel;
Souweidane, Mark M.

Publication type:

Article

Marker (+) CNS germ cell tumors in remission: Are surveillance MRI scans necessary?

Published in:

Pediatric Blood & Cancer, 2014, v. 61, n. 5, p. 853, doi. 10.1002/pbc.24888

By:

Martinez, Sybila;
Khakoo, Yasmin;
Gilheeney, Stephen;
Kramer, Kim;
Wolden, Suzanne;
Souweidane, Mark;
Dunkel, Ira J.

Publication type:

Article

Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma.

Published in:

Pediatric Blood & Cancer, 2012, v. 58, n. 3, p. 469, doi. 10.1002/pbc.23132

By:

Modak, Shakeel;
Cheung, Irene Y.;
Kushner, Brian H.;
Kramer, Kim;
Reich, Lilian;
Cheung, Nai-Kong V.

Publication type:

Article

High-dose carboplatin-irinotecan-temozolomide: Treatment option for neuroblastoma resistant to topotecan.

Published in:

Pediatric Blood & Cancer, 2011, v. 56, n. 3, p. 403, doi. 10.1002/pbc.22855

By:

Kushner, Brian H.;
Kramer, Kim;
Modak, Shakeel;
Cheung, Nai-Kong V.

Publication type:

Article

Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastoma.

Published in:

Pediatric Blood & Cancer, 2010, v. 55, n. 1, p. 76, doi. 10.1002/pbc.22452

By:

Bhandari, Sonal;
Cheung, Nai-Kong V.;
Kushner, Brian H.;
Kramer, Kim;
Modak, Shakeel;
Larson, Steven M.;
Yeh, Samuel;
Heller, Glenn;
Sklar, Charles A.

Publication type:

Article

A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.

Published in:

Pediatric Blood & Cancer, 2009, v. 53, n. 7, p. 1340, doi. 10.1002/pbc.22243

By:

Kushner, Brian H.;
Kramer, Kim;
Modak, Shakeel;
Akhurst, Timothy J.;
Cheung, Nai-Kong V.

Publication type:

Article

Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma.

Published in:

Pediatric Blood & Cancer, 2009, v. 53, n. 1, p. 17, doi. 10.1002/pbc.21931

By:

Kushner, Brian H.;
Kramer, Kim;
Modak, Shakeel;
Qin, Li-Xuan;
Yataghena, Karima;
Jhanwar, Suresh C.;
Cheung, Nai-Kong V.

Publication type:

Article

Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: Possible leukemogenic role of temozolomide.

Published in:

Pediatric Blood & Cancer, 2008, v. 51, n. 4, p. 552, doi. 10.1002/pbc.21658

By:

Kushner, Brian H.;
Laquaglia, Michael P.;
Kramer, Kim;
Modak, Shakeel;
Cheung, Nai-Kong V.

Publication type:

Article

Transient sialoadenitis: A complication of 131I-metaiodobenzylguanidine therapy.

Published in:

Pediatric Blood & Cancer, 2008, v. 50, n. 6, p. 1271, doi. 10.1002/pbc.21391

By:

Modak, Shakeel;
Pandit-Taskar, Neeta;
Kushner, Brian H.;
Kramer, Kim;
Smith-Jones, Peter;
Larson, Steven;
Cheung, Nai-Kong V.

Publication type:

Article

Brain-sparing radiotherapy for neuroblastoma skull metastases.

Published in:

Pediatric Blood & Cancer, 2008, v. 50, n. 6, p. 1163, doi. 10.1002/pbc.21384

By:

Wolden, Suzanne L.;
Barker, Christopher A.;
Kushner, Brian H.;
Bodduluri, Haritha;
Della-Biancia, Cesar;
Kramer, Kim;
Modak, Shakeel;
Cheung, Nai-Kong V.

Publication type:

Article

A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies.

Published in:

Pediatric Blood & Cancer, 2007, v. 49, n. 3, p. 261, doi. 10.1002/pbc.21045

By:

Gilheeney, Stephen W.;
Lyden, David C.;
Sgouros, Shirley;
Antunes, Nuno;
Gerald, William;
Kramer, Kim;
Lis, Eric;
Meyers, Paul;
Rosen, Nancy;
Thaler, Howard T.;
Trippett, Tanya;
Wexler, Leonard;
Dunkel, Ira J.

Publication type:

Article

High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: Broad implications for immunotherapy.

Published in:

Pediatric Blood & Cancer, 2007, v. 48, n. 4, p. 430, doi. 10.1002/pbc.20765

By:

Kushner, Brian H.;
Cheung, Irene Y.;
Kramer, Kim;
Modak, Shakeel;
Cheung, Nai-Kong V.

Publication type:

Article

Liver involvement in neuroblastoma: The memorial Sloan-Kettering experience supports treatment reduction in young patients.

Published in:

Pediatric Blood & Cancer, 2006, v. 46, n. 3, p. 278, doi. 10.1002/pbc.20564

By:

Kushner, Brian H.;
Kramer, Kim;
LaQuaglia, Michael P.;
Modak, Shakeel;
Cheung, Nai-Kong V.

Publication type:

Article

Long-term complications in survivors of advanced stage neuroblastoma.

Published in:

Pediatric Blood & Cancer, 2005, v. 45, n. 3, p. 324, doi. 10.1002/pbc.20331

By:

Laverdière, Caroline;
Cheung, Nai-Kong V.;
Kushner, Brian H.;
Kramer, Kim;
Modak, Shakeel;
LaQuaglia, Michael P.;
Wolden, Suzanne;
Ness, Kirsten K.;
Gurney, James G.;
Sklar, Charles A.

Publication type:

Article

Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia.

Published in:

Pediatric Blood & Cancer, 2005, v. 45, n. 2, p. 176, doi. 10.1002/pbc.20282

By:

Bussel, James B.;
Zacharoulis, Stergios;
Kramer, Kim;
McFarland, Janice G.;
Pauliny, Joanne;
Kaplan, Cecile

Publication type:

Article

Evaluating the Utility of a 'N-of-1' Precision Cancer Medicine Strategy: The Case for 'Time-to-Subsequent-Disease Progression'.

Published in:

Oncology, 2016, v. 91, n. 6, p. 299, doi. 10.1159/000450682

By:

Markman, Maurie;
Kramer, Kim;
alvarez, Ricardo H.;
Weiss, Glen J.;
ahn, Eugene;
Daneker, George William

Publication type:

Article

Large Congenital Melanotic Nevi in an Extremity with Neurocutaneous Melanocytosis.

Published in:

Pediatric Dermatology, 2009, v. 26, n. 1, p. 79, doi. 10.1111/j.1525-1470.2008.00828.x

By:

Becher, Oren J.;
Souweidane, Mark;
Lavi, Ehud;
Kramer, Kim;
Lis, Eric;
Marghoob, Ashfaq A.;
Khakoo, Yasmin

Publication type:

Article

Retinal Hemorrhages Following Cardiopulmonary Resuscitation.

Published in:

Clinical Pediatrics, 1993, v. 32, n. 6, p. 366, doi. 10.1177/000992289303200610

By:

Kramer, Kim;
Goldstein, Brahm

Publication type:

Article

Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma.

Published in:

Cancer (0008543X), 2006, v. 107, n. 2, p. 417, doi. 10.1002/cncr.22004

By:

Kushner, Brian H.;
Budnick, Amy;
Kramer, Kim;
Modak, Shakeel;
Cheung, Nai-Kong V.

Publication type:

Article

Five-day courses of irinotecan as palliative therapy for patients with neuroblastoma.

Published in:

Cancer (0008543X), 2005, v. 103, n. 4, p. 858

By:

Brian H. Kushner;
Kim Kramer;
Shakeel Modak;
Nai-Kong V. Cheung

Publication type:

Article

Five-day courses of irinotecan as palliative therapy for patients with neuroblastoma.

Published in:

2005

By:

Kushner, Brian H;
Kramer, Kim;
Modak, Shakeel;
Cheung, Nai-Kong V

Publication type:

journal article

Chronic neuroblastoma.

Published in:

Cancer (0008543X), 2002, v. 95, n. 6, p. 1366, doi. 10.1002/cncr.10800

By:

Kushner, Brian H.;
Kramer, Kim;
Cheung, Nai-Kong V.

Publication type:

Article

Neuroblastoma metastatic to the central nervous system.

Published in:

Cancer (0008543X), 2001, v. 91, n. 8, p. 1510, doi. 10.1002/1097-0142(20010415)91:8<1510::AID-CNCR1159>3.0.CO;2-I

By:

Kramer, Kim;
Kushner, Brian;
Heller, Glenn;
Cheung, Nai-Kong V.

Publication type:

Article

Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma.

Published in:

Cancer (0008543X), 2000, v. 89, n. 10, p. 2122, doi. 10.1002/1097-0142(20001115)89:10<2122::AID-CNCR13>3.0.CO;2-K

By:

Kushner, Brian H.;
Heller, Glenn;
Kramer, Kim;
Cheung, Nai-Kong V.

Publication type:

Article

Treatment and outcome of adult‐onset neuroblastoma.

Published in:

International Journal of Cancer, 2018, v. 143, n. 5, p. 1249, doi. 10.1002/ijc.31399

By:

Suzuki, Maya;
Kushner, Brian H.;
Kramer, Kim;
Basu, Ellen M.;
Roberts, Stephen S.;
Hammond, William J.;
LaQuaglia, Michael P.;
Wolden, Suzanne L.;
Cheung, Nai‐Kong V.;
Modak, Shakeel

Publication type:

Article

A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma.

Published in:

International Journal of Cancer, 2017, v. 140, n. 2, p. 480, doi. 10.1002/ijc.30440

By:

Kushner, Brian H.;
Cheung, Nai‐Kong V.;
Modak, Shakeel;
Becher, Oren J.;
Basu, Ellen M.;
Roberts, Stephen S.;
Kramer, Kim;
Dunkel, Ira J.

Publication type:

Article

Key role for myeloid cells: Phase II results of anti-GD2 antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma.

Published in:

International Journal of Cancer, 2014, v. 135, n. 9, p. 2199, doi. 10.1002/ijc.28851

By:

Cheung, Nai‐Kong V.;
Cheung, Irene Y.;
Kramer, Kim;
Modak, Shakeel;
Kuk, Deborah;
Pandit‐Taskar, Neeta;
Chamberlain, Elizabeth;
Ostrovnaya, Irina;
Kushner, Brian H.

Publication type:

Article

Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies.

Published in:

Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01383-4

By:

Kramer, Kim;
Pandit-Taskar, Neeta;
Kushner, Brian H.;
Zanzonico, Pat;
Humm, John L.;
Tomlinson, Ursula;
Donzelli, Maria;
Wolden, Suzanne L.;
Haque, Sophia;
Dunkel, Ira;
Souweidane, Mark M.;
Greenfield, Jeffrey P.;
Tickoo, Satish;
Lewis, Jason S.;
Lyashchenko, Serge K.;
Carrasquillo, Jorge A.;
Chu, Bae;
Horan, Christopher;
Larson, Steven M.;
Cheung, Nai-Kong V.

Publication type:

Article

A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.

Published in:

PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0178593

By:

Becher, Oren J.;
Millard, Nathan E.;
Modak, Shakeel;
Kushner, Brian H.;
Haque, Sofia;
Spasojevic, Ivan;
Trippett, Tanya M.;
Gilheeney, Stephen W.;
Khakoo, Yasmin;
Lyden, David C.;
De Braganca, Kevin C.;
Kolesar, Jill M.;
Huse, Jason T.;
Kramer, Kim;
Cheung, Nai-Kong V.;
Dunkel, Ira J.

Publication type:

Article

Craniospinal irradiation and/or intraventricular radioimmunotherapy after high‐dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma—Safety and outcomes.

Published in:

Pediatric Blood & Cancer, 2024, v. 71, n. 11, p. 1, doi. 10.1002/pbc.31297

By:

Sait, Sameer Farouk;
Kernan, Nancy A.;
Klein, Elizabeth;
Spitzer, Barbara;
Levy, Carolyn Fein;
Fish, Jonathan;
Yildirim, Onur;
Haque, Sofia;
Donzelli, Maria;
Bernot, Mauricio Rendon;
Abramson, David H.;
Francis, Jasmine H.;
Khakoo, Yasmin;
Karajannis, Matthias;
Sands, Stephen;
Pandit‐Taskar, Neeta;
Wolden, Suzanne;
Kramer, Kim;
Dunkel, Ira J.

Publication type:

Article

Ovarian function in female survivors of high‐risk neuroblastoma.

Published in:

Pediatric Blood & Cancer, 2024, v. 71, n. 9, p. 1, doi. 10.1002/pbc.31181

By:

Jimenez‐Kurlander, Lauren;
DeRosa, Amelia;
Kostrzewa, Caroline E.;
Moskowitz, Chaya S.;
Bogardus, Kimberly;
Antal, Zoltan;
Wolden, Suzanne;
La Quaglia, Michael P.;
Basu, Ellen M.;
Cardenas, Fiorella Iglesias;
Kramer, Kim;
Kushner, Brian H.;
Cheung, Nai‐Kong V.;
Modak, Shakeel;
Friedman, Danielle Novetsky

Publication type:

Article

Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma.

Published in:

Pediatric Blood & Cancer, 2023, v. 70, n. 2, p. 1, doi. 10.1002/pbc.30075

By:

Tringale, Kathryn R.;
Wolden, Suzanne L.;
Casey, Dana L.;
Kushner, Brian H.;
Luo, Leo;
Pandit‐Taskar, Neeta;
Souweidane, Mark;
Cheung, Nai‐Kong V.;
Modak, Shakeel;
Basu, Ellen M.;
Kramer, Kim

Publication type:

Article

Theranostic Intratumoral Convection-Enhanced Delivery of 124I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1364, doi. 10.2967/jnumed.123.266365

By:

Pandit-Taskar, Neeta;
Zanzonico, Pat B.;
Grkovski, Milan;
Donzelli, Maria;
Vietri, Scott M.;
Horan, Christopher;
Serencsits, Brian;
Prasad, Kavya;
Lyashchenko, Serge;
Kramer, Kim;
Dunkel, Ira J.;
Souweidane, Mark M.

Publication type:

Article

Radioimmunoscintigraphy and Pretreatment Dosimetry of 131I-Omburtamab for Planning Treatment of Leptomeningeal Disease.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 6, p. 946, doi. 10.2967/jnumed.122.265131

By:

Pandit-Taskar, Neeta;
Grkovski, Milan;
Zanzonico, Pat B.;
Pentlow, Keith S.;
Modak, Shakeel;
Kramer, Kim;
Humm, John L.

Publication type:

Article